Dermatology Centre, Salford Royal NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, UK.
J Pathol. 2013 Oct;231(2):236-47. doi: 10.1002/path.4233.
Lichen planopilaris (LPP) is a chronic inflammatory disease of unknown pathogenesis that leads to permanent hair loss. Whilst destruction of epithelial hair follicle stem cells (eHFSCs) that reside in an immunologically protected niche of the HF epithelium, the bulge, is a likely key event in LPP pathogenesis, this remains to be demonstrated. We have tested the hypotheses that bulge immune privilege (IP) collapse and inflammation-induced eHFSC death are key components in the pathogenesis of LPP. Biopsies of lesional and non-lesional scalp skin from adult LPP patients (n = 42) were analysed by quantitative (immuno)histomorphometry, real-time quantitative polymerase chain reaction (qRT-PCR), laser capture microdissection and microarray analysis, or skin organ culture. At both the protein and transcriptional level, lesional LPP HFs showed evidence for bulge IP collapse (ie increased expression of MHC class I and II, β2microglobulin; reduced TGFβ2 and CD200 expression). This was accompanied by a Th1-biased cytotoxic T cell response (ie increased CD8(+) GranzymeB(+) T cells and CD123(+) plasmacytoid dendritic cells, with increased CXCR3 expression) and increased expression of interferon-inducible chemokines (CXCL9/10/11). Interestingly, lesional LPP eHFSCs showed both increased proliferation and apoptosis in situ. Microarray analysis revealed a loss of eHFSC signatures and increased expression of T cell activation/binding markers in active LPP, while bulge PPARγ transcription was unaltered compared to non-lesional LPP HFs. In organ culture of non-lesional LPP skin, interferon-γ (IFNγ) induced bulge IP collapse. LPP is an excellent model disease for studying and preventing immune destruction of human epithelial stem cells in situ. These novel findings raise the possibility that LPP represents an autoimmune disease in whose pathogenesis IFNγ-induced bulge IP collapse plays an important role. Therapeutically, bulge IP protection/restoration may help to better manage this highly treatment-resistant cicatricial alopecia.
瘢痕性类扁平苔藓(LPP)是一种病因不明的慢性炎症性疾病,可导致永久性脱发。虽然位于毛囊上皮免疫豁免部位(HF 上皮的隆起处)的上皮毛囊干细胞(eHFSCs)的破坏是 LPP 发病机制中的一个关键事件,但这仍有待证明。我们已经检验了以下假设:即隆起处免疫特权(IP)崩溃和炎症诱导的 eHFSC 死亡是 LPP 发病机制中的关键组成部分。对来自成人 LPP 患者(n = 42)的皮损和非皮损头皮皮肤活检标本进行了定量(免疫)组织形态计量学、实时定量聚合酶链反应(qRT-PCR)、激光捕获显微切割和微阵列分析或皮肤器官培养分析。在蛋白和转录水平上,皮损 LPP 毛囊显示出隆起处 IP 崩溃的证据(即 MHC 类 I 和 II、β2 微球蛋白表达增加;TGFβ2 和 CD200 表达减少)。这伴随着 Th1 偏向的细胞毒性 T 细胞反应(即 CD8+GranzymeB+T 细胞和 CD123+浆细胞样树突细胞增加,CXCR3 表达增加)和干扰素诱导的趋化因子(CXCL9/10/11)表达增加。有趣的是,皮损 LPP eHFSCs 原位显示增殖和凋亡增加。微阵列分析显示,在活跃的 LPP 中,eHFSC 特征丢失,T 细胞激活/结合标志物表达增加,而与非皮损 LPP 毛囊相比,隆起处 PPARγ 转录无改变。在非皮损 LPP 皮肤的器官培养中,干扰素-γ(IFNγ)诱导隆起处 IP 崩溃。LPP 是研究和预防人上皮干细胞原位免疫破坏的理想模型疾病。这些新发现提出了一种可能性,即 LPP 代表一种自身免疫性疾病,其中 IFNγ 诱导的隆起处 IP 崩溃发挥了重要作用。在治疗方面,隆起处 IP 保护/恢复可能有助于更好地治疗这种高度难治性瘢痕性脱发。